듀얼 챔버형 프리필드 시린지 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Dual Chamber Prefilled Syringes Market Growth & Trends:

The global dual chamber prefilled syringes market size is expected to reach USD 247.8 million by 2030, at a projected CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. They enhance patient safety by minimizing the risk of dosing errors and contamination associated with traditional vial-and-syringe methods. The pre-measured doses ensure accurate and consistent administration, reducing preparation time and simplifying the process for healthcare professionals. This is particularly beneficial in emergency situations or in settings where speed and precision are crucial.

The all-in-one design is user-friendly and reduces the complexity of multi-step preparation processes. Moreover, dual chamber prefilled syringes can improve storage and shelf-life, as the drug and diluent are kept separate until needed. For instance, in September 2022, Dara Pharma's participation in the PDA Japan Chapter's seminar highlights their advancements in dual chamber prefilled syringes, particularly in powder dosing and freeze-drying. This exposure boosts their credibility and visibility in the Japanese pharmaceutical market, showcasing their innovative solutions and technological capabilities. Their presentations demonstrated the extended shelf life and improved properties of medications using these technologies, fostering interest and potential collaborations within the industry.

Dual Chamber Prefilled Syringes Market Report Highlights:

• Based on material, the glass segment accounted for the largest revenue share of 51.4% in 2023 as it offers superior drug stability and compatibility, preventing interactions between the drug and the container.
• Based on material, the plastic segment is expected to grow at the fastest CAGR of 7.8% during the forecast period as plastic is lighter, more resistant to breakage, and offers improved safety for patients and healthcare providers.
• Based on application, the vaccines and immunizations segment accounted for the largest revenue share of 25.8% in 2023 due to accurate dosing and simplifying the reconstitution process, which enhanced safety and reduced preparation time.
• Based on application, the oncology segment is expected to grow at the fastest CAGR of 6.9% during the forecast period. They offer precise dosing and convenient reconstitution, improving the safety and efficacy of complex chemotherapy treatments.
• Based on distribution channel, the hospitals segment held the largest revenue share of 51.8% in 2023 as they streamline drug preparation, reduce medication errors, and enhance patient safety by ensuring accurate dosing and easy reconstitution.
• Based on distribution channel, the mail order pharmacies segment is expected to grow at the fastest CAGR of 6.6% during the forecast period as they enhance patient convenience and adherence by providing ready-to-use, accurately dosed medications that simplify the administration process at home.
• In 2023, North America dominated with a share of 32.3%, as this region is driven by advanced healthcare infrastructure, growth of the biopharmaceutical sector, and significant healthcare expenditure.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1 Segment Definitions
  • 1.1.2. Material
  • 1.1.3. Application
  • 1.1.4. Distribution Channel
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material outlook
  • 2.2.2. Application outlook
  • 2.2.3. Distribution Channel outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Dual Chamber Prefilled Syringes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Patient preference and compliance
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Cross contamination risk
    • 3.2.2.2. High production costs
• 3.3. Dual Chamber Prefilled Syringes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Dual Chamber Prefilled Syringes Market: Material Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Dual Chamber Prefilled Syringes Market: Material Movement Analysis
• 4.3. Dual Chamber Prefilled Syringes Market by Material Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Glass
  • 4.5.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Plastic
  • 4.6.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Dual Chamber Prefilled Syringes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Dual Chamber Prefilled Syringes Market: Application Movement Analysis
• 5.3. Dual Chamber Prefilled Syringes Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Vaccines and Immunizations
  • 5.5.1. Vaccines and Immunizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Anaphylaxis
  • 5.6.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Rheumatoid Arthritis
  • 5.7.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Diabetes
  • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Autoimmune Diseases
  • 5.9.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Oncology
  • 5.10.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. Others
  • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Dual Chamber Prefilled Syringes Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Dual Chamber Prefilled Syringes Market: Distribution Channel Movement Analysis
• 6.3. Dual Chamber Prefilled Syringes Market by Distribution Channel Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Mail Order Pharmacies
  • 6.6.1. Mail Order Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Ambulatory Surgery Centers
  • 6.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Dual Chamber Prefilled Syringes Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Dual Chamber Prefilled Syringes Market movement analysis
• 7.3. Dual Chamber Prefilled Syringes Market: Regional Estimates & Trend Analysis by Technology & Distribution Channel
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Dual Chamber Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Gerresheimer
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Nipro Corporation
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. SCHOTT AG
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Vetter Pharma-Fertigung GmbH & Co. KG
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. ARTE Corporation
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Credence MedSystems, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives